Amplatzer Amulet™ left atrial appendage occluder: A step-by-step guide to device implantation

Recently receiving Food and Drug Administration approval, the Amplatzer Amulet™ left atrial appendage occluder device (Abbott Medical Inc.) provides a dual seal mechanism alternative to the commercially available Watchman FLX or Watchman 2.5 device for embolic stroke prevention in patients with nonvalvular atrial fibrillation. This step-by-step review will cover patient selection, preprocedure imaging assessment, device sizing, device preparation, implant target position assessment, implant technique and troubleshooting, and immediate postimplant follow-up.